这是一篇来自已证抗体库的有关
人类 MICA的综述,是根据16篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合MICA 抗体。
MICA 同义词: MIC-A; PERB11.1
BioLegend
小鼠 单克隆(6D4) | | BioLegend MICA抗体(BioLegend, 320906)被用于被用于流式细胞仪在人类样本上 (图 1a). J Exp Clin Cancer Res (2021) ncbi |
小鼠 单克隆(6D4) | | BioLegend MICA抗体(BioLegend, 320906)被用于被用于流式细胞仪在人类样本上 (图 3). Stem Cell Reports (2020) ncbi |
小鼠 单克隆(6D4) | | BioLegend MICA抗体(Biolegend, 320906)被用于被用于流式细胞仪在人类样本上 (图 2b). Biosci Rep (2019) ncbi |
小鼠 单克隆(6D4) | - 免疫细胞化学; 人类; 图 1b
- 免疫组化; 人类; 图 2a
| BioLegend MICA抗体(BioLegend, 6D4)被用于被用于免疫细胞化学在人类样本上 (图 1b) 和 被用于免疫组化在人类样本上 (图 2a). Br J Cancer (2017) ncbi |
小鼠 单克隆(6D4) | | BioLegend MICA抗体(BioLegend, 6D4)被用于被用于流式细胞仪在人类样本上 (图 s3g). Oncogene (2017) ncbi |
小鼠 单克隆(6D4) | | BioLegend MICA抗体(Biolegend, 6D4)被用于被用于流式细胞仪在人类样本上 (图 4). Sci Rep (2016) ncbi |
小鼠 单克隆(6D4) | | BioLegend MICA抗体(Biolegend, 6D4)被用于被用于流式细胞仪在人类样本上 (图 7). Mucosal Immunol (2016) ncbi |
小鼠 单克隆(6D4) | | BioLegend MICA抗体(Biolegend, 6D4)被用于被用于流式细胞仪在人类样本上. Immunology (2014) ncbi |
小鼠 单克隆(6D4) | | BioLegend MICA抗体(Biolegend, 6D4)被用于. Int Immunol (2014) ncbi |
安迪生物R&D
小鼠 单克隆(159227) | | 安迪生物R&D MICA抗体(Biotechne, 159,227)被用于被用于流式细胞仪在人类样本上 (图 2c). Oncoimmunology (2022) ncbi |
小鼠 单克隆(159227) | | 安迪生物R&D MICA抗体(R&D Systems, 159227)被用于被用于流式细胞仪在人类样本上 (图 2b). BMC Biol (2021) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(2C10) | | 圣克鲁斯生物技术 MICA抗体(Santa Cruz, sc-23870)被用于被用于免疫印迹在人类样本上浓度为1:250 (图 s4c). Nat Commun (2020) ncbi |
小鼠 单克隆(2C10) | | 圣克鲁斯生物技术 MICA抗体(Santa, 2C10)被用于被用于流式细胞仪在人类样本上 (图 1). J Biol Chem (2018) ncbi |
小鼠 单克隆(2C10) | - 流式细胞仪; 人类; 图 3a
- 免疫印迹; 人类; 1:100; 图 5
| 圣克鲁斯生物技术 MICA抗体(Santa Cruz, 2C10)被用于被用于流式细胞仪在人类样本上 (图 3a) 和 被用于免疫印迹在人类样本上浓度为1:100 (图 5). Front Immunol (2016) ncbi |
小鼠 单克隆(F-6) | - 免疫组化-石蜡切片; 人类; 1:800; 图 1
| 圣克鲁斯生物技术 MICA抗体(Santa Cruz Biotechnology, sc-137242)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:800 (图 1). Cancer Sci (2016) ncbi |
赛默飞世尔
小鼠 单克隆(6D4) | | 赛默飞世尔 MICA抗体(eBioscience, 6D4)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫组化在人类样本上. Exp Mol Pathol (2014) ncbi |
Secchiari F, Nu xf1 ez S, Sierra J, Ziblat A, Regge M, Raffo Iraolagoitia X,
et al. The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology. Oncoimmunology. 2022;11:2104991
pubmed 出版商
Zhu Y, Xie J, Shi J. Rac1/ROCK-driven membrane dynamics promote natural killer cell cytotoxicity via granzyme-induced necroptosis. BMC Biol. 2021;19:140
pubmed 出版商
Hirano M, Imai Y, Kaito Y, Murayama T, Sato K, Ishida T,
et al. Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma. J Exp Clin Cancer Res. 2021;40:110
pubmed 出版商
Mahameed M, Boukeileh S, Obiedat A, Darawshi O, Dipta P, Rimon A,
et al. Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy. Nat Commun. 2020;11:1304
pubmed 出版商
Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A,
et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59
pubmed 出版商
Tang S, Fu H, Xu Q, Zhou Y. miR-20a regulates sensitivity of colorectal cancer cells to NK cells by targeting MICA. Biosci Rep. 2019;:
pubmed 出版商
McCarthy M, Moncayo G, Hiron T, Jakobsen N, Valli A, Soga T,
et al. Purine nucleotide metabolism regulates expression of the human immune ligand MICA. J Biol Chem. 2018;293:3913-3924
pubmed 出版商
Ghadially H, Brown L, Lloyd C, Lewis L, LEWIS A, Dillon J,
et al. MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue. Br J Cancer. 2017;116:1208-1217
pubmed 出版商
Moncayo G, Lin D, McCarthy M, Watson A, O Callaghan C. MICA Expression Is Regulated by Cell Adhesion and Contact in a FAK/Src-Dependent Manner. Front Immunol. 2016;7:687
pubmed 出版商
Sauer M, Schuldner M, Hoffmann N, Cetintas A, Reiners K, Shatnyeva O,
et al. CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells. Oncogene. 2017;36:933-941
pubmed 出版商
Ritter C, Fan K, Paulson K, Nghiem P, Schrama D, Becker J. Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma. Sci Rep. 2016;6:21678
pubmed 出版商
Tsukagoshi M, Wada S, Yokobori T, Altan B, Ishii N, Watanabe A,
et al. Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma. Cancer Sci. 2016;107:116-22
pubmed 出版商
Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J,
et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70
pubmed 出版商
Ikeshita S, Miyatake Y, Otsuka N, Kasahara M. MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques. Exp Mol Pathol. 2014;97:171-5
pubmed 出版商
Vogel K, Thomann S, Vogel B, Schuster P, Schmidt B. Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections. Immunology. 2014;143:588-600
pubmed 出版商
Watanabe M, Kudo Y, Kawano M, Nakayama M, Nakamura K, Kameda M,
et al. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus). Int Immunol. 2014;26:597-606
pubmed 出版商